Risk of venous thromboembolism in women with endometriosis

Hanke M.G. Wiegers, H M G Wiegers, Luuk J.J. Scheres, L J J Scheres, L Tahir, Lara Tahir, Tahir L, B A Hutten, Hutten BA, S Middeldorp, Saskia Middeldorp, Velja Mijatovic, V. Mijatovic
Thrombosis research · 2022 · vol. 217 , pp. 104–106 · doi:10.1016/j.thromres.2022.07.014 · PMID:35932497 · W4289260566
letter OA: green CC0 ⤵ 6 in-corpus citations
🔓 Open OA copy Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-13 ⓘ

This paper investigates the risk of venous thromboembolism in women diagnosed with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text ⓘ

This paper examines the risk of venous thromboembolism in women with endometriosis, using data drawn from existing evidence rather than collecting new endometriosis cohorts. It reports an association between endometriosis and an increased risk of venous thromboembolism, with the analysis considering relevant hormonal and thrombosis-related factors at a high level. A key limitation explicitly noted is that the study design and available evidence may be influenced by confounding and the constraints of the underlying data sources. This paper is centrally about endometriosis — specifically, it evaluates how endometriosis relates to venous thromboembolism risk.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,446 characters · extracted from oa-html · click to expand
@article{87f1f46a5d2f4eb0b2b831f9014bb31d, title = "Risk of venous thromboembolism in women with endometriosis", keywords = "Endometriosis, Hormones, Risk, Thrombosis, Women", author = "Wiegers, \{H. M. G.\} and Scheres, \{L. J. J.\} and L. Tahir and Hutten, \{B. A.\} and S. Middeldorp and V. Mijatovic", note = "Funding Information: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: HW and LT have nothing to declare. BAH reports receiving a research grant from Silence Therapeutics outside the scope of this work. SM reports grants and personal fees from Bayer, BMS Pfizer, Boehringer Ingelheim, Daiichi Sankyo, Portola, all during the conduct of the study; personal fees form Abbvie, personal fees from Sanofi, all outside the scope of the submitted work. LS received funding for the printing of his doctoral thesis (2019) from the Dutch Heart Foundation, Dutch Federation of Coagulation Clinics, Stichting tot Steun Promovendi Vasculaire Geneeskunde, Bayer, Daiichi Sankyo, LEO Pharma, and Pfizer, outside the scope of this work. VM reports receiving research grants from Ferring, Merck and Guerbet outside the scope of this work.", year = "2022", month = sep, day = "1", doi = "10.1016/j.thromres.2022.07.014", language = "English", volume = "217", pages = "104--106", journal = "Thrombosis research", issn = "0049-3848", publisher = "Elsevier Limited", }

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (9)

Cited by (11)

Source provenance

europepmc
last seen: 2026-09-04T06:17:57.233406+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-08-06T06:07:40.701308+00:00
License: CC0 · commercial use OK